Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,688 | 120 | 70.0% |
| Travel and Lodging | $2,007 | 6 | 30.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CVRx, Inc. | $1,700 | 7 | $0 (2024) |
| Abbott Laboratories | $1,429 | 14 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $816.67 | 29 | $0 (2022) |
| Biogen, Inc. | $612.61 | 12 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $532.32 | 30 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $250.46 | 2 | $0 (2023) |
| UCB, Inc. | $212.52 | 2 | $0 (2023) |
| ABBVIE INC. | $183.40 | 8 | $0 (2022) |
| SK Life Science, Inc. | $158.32 | 2 | $0 (2022) |
| PFIZER INC. | $146.75 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,041 | 11 | CVRx, Inc. ($1,700) |
| 2023 | $1,981 | 31 | Abbott Laboratories ($1,406) |
| 2022 | $1,743 | 46 | Biohaven Pharmaceutical Holding Company Ltd. ($816.67) |
| 2021 | $931.06 | 38 | Biohaven Pharmaceuticals, Inc. ($532.32) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $109.16 | General |
| 08/21/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $115.61 | General |
| Category: AMANTADINE | ||||||
| 08/11/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Neuromodulation | ||||||
| 07/10/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $93.92 | General |
| Category: Neurology | ||||||
| 05/05/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $54.99 | General |
| Category: Heart Failure and Hypertension | ||||||
| 05/04/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $97.97 | General |
| Category: Heart Failure and Hypertension | ||||||
| 05/04/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $76.07 | General |
| Category: Heart Failure and Hypertension | ||||||
| 05/04/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $65.63 | General |
| Category: Heart Failure and Hypertension | ||||||
| 05/03/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $741.97 | General |
| Category: Heart Failure and Hypertension | ||||||
| 05/03/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $466.34 | General |
| Category: Heart Failure and Hypertension | ||||||
| 05/03/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $196.75 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/05/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $87.52 | General |
| 12/05/2023 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Neuromodulation | ||||||
| 12/01/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: PAIN | ||||||
| 11/15/2023 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $144.35 | General |
| Category: Neuromodulation | ||||||
| 10/05/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: PAIN | ||||||
| 09/14/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: Neurology | ||||||
| 09/05/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: PAIN | ||||||
| 08/17/2023 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: Neuromodulation | ||||||
| 07/17/2023 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $136.69 | General |
| Category: Neuromodulation | ||||||
| 07/13/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: Neurology | ||||||
| 06/08/2023 | Biogen, Inc. | Tysabri (Biological) | Food and Beverage | In-kind items and services | $89.86 | General |
| Category: Neurology | ||||||
| 06/02/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: PAIN | ||||||
| 05/24/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: Neurology | ||||||
| 05/18/2023 | Abbott Laboratories | INFINITY (Device) | Travel and Lodging | In-kind items and services | $573.30 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 401 | 475 | $131,979 | $31,239 |
| 2022 | 5 | 465 | 527 | $144,273 | $35,370 |
| 2021 | 6 | 435 | 560 | $143,238 | $38,123 |
| 2020 | 6 | 477 | 648 | $151,140 | $35,597 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 151 | 195 | $56,355 | $11,174 | 19.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 124 | 146 | $33,288 | $10,758 | 32.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 58 | 63 | $25,578 | $5,205 | 20.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 39 | $6,201 | $2,002 | 32.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $7,497 | $1,617 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 15 | $3,060 | $482.46 | 15.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 138 | 166 | $44,794 | $10,445 | 23.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 125 | 149 | $33,972 | $9,598 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 66 | 73 | $26,938 | $6,798 | 25.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 26 | $11,488 | $3,131 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 57 | $13,452 | $2,301 | 17.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 30 | $9,480 | $1,945 | 20.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 26 | $4,149 | $1,152 | 27.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 189 | 263 | $62,068 | $15,687 | 25.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 104 | 137 | $43,292 | $11,548 | 26.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 82 | 97 | $22,116 | $6,470 | 29.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 20 | 20 | $8,860 | $2,552 | 28.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 21 | $3,360 | $992.88 | 29.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 22 | $3,542 | $872.39 | 24.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 232 | 339 | $74,904 | $15,987 | 21.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 119 | 162 | $47,808 | $11,352 | 23.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 67 | 85 | $19,186 | $5,766 | 30.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 26 | 29 | $4,564 | $1,396 | 30.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 16 | 16 | $1,857 | $808.80 | 43.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 17 | $2,821 | $286.74 | 10.2% |
About Brandi Dunford, FNP-C
Brandi Dunford, FNP-C is a Family healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2018. The National Provider Identifier (NPI) number assigned to this provider is 1003387861.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brandi Dunford, FNP-C has received a total of $6,695 in payments from pharmaceutical and medical device companies, with $2,041 received in 2024. These payments were reported across 126 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($4,688).
As a Medicare-enrolled provider, Dunford has provided services to 1,778 Medicare beneficiaries, totaling 2,210 services with total Medicare billing of $140,328. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Tyler, TX
- Active Since 12/05/2018
- Last Updated 12/05/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1003387861
Products in Payments
- Barostim Neo System (Device) $1,700
- NURTEC ODT (Drug) $1,471
- INFINITY (Device) $1,386
- ADUHELM (Biological) $256.90
- INGREZZA (Drug) $250.46
- UBRELVY (Drug) $183.40
- XCOPRI (Drug) $158.32
- Aimovig (Biological) $131.75
- Briviact (Drug) $125.00
- TYSABRI (Biological) $122.39
- Gocovri (Drug) $115.61
- Omnia (Device) $104.59
- Tysabri (Biological) $89.86
- Optune (Device) $88.54
- VUMERITY (Drug) $67.17
- NOURIANZ (Drug) $59.07
- PROCLAIM (Device) $42.87
- ELIQUIS (Drug) $25.20
- BRILINTA (Drug) $15.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Tyler
Jonathan King, Np, NP
Family — Payments: $83,965
Kirsten Stuber, Fnp-Bc, FNP-BC
Family — Payments: $66,199
Machelle Mcdowell, Fnp, Np-C, FNP, NP-C
Family — Payments: $63,178
Amanda George, Aprn, Bc Fnp, APRN, BC FNP
Family — Payments: $8,588
Tiffiney Mcmakin, Np, NP
Family — Payments: $6,483
Natalye Combs, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $6,338